Cyclophosphamide
NDC 83831-117, Cyclophosphamide, injection, from Avyxa Pharma, LLC.
- Product NDC
- 83831-117
- Status
- Listed
- Labeler
- Avyxa Pharma, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210852
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83831-117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOPHOSPHAMIDE1 g/2mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83831-117-02 | 83831011702 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83831-117-02) / 2 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6f593585-e0dd-48bc-bd2b-c6c787e0b98cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=83831-117
Use it
Look up 83831-117 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83831-117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83831-117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.